Key result
CD36 deficiency in mice led to the differential expression of 30 genes involved in fatty acid metabolism, angiogenesis/apoptosis, and cell structure pathways.
Answers are grounded in this paper and cite their sources.
CD36 deficiency in mice leads to differential expression of genes involved in fatty acid metabolism, angiogenesis/apoptosis, and cell structure, providing insight into the molecular mechanisms of CD36-related hypertrophic cardiomyopathy.
CD36 is a multifunctional membrane-type receptor glycoprotein that reacts with oxidized low-density lipoprotein and long-chain fatty acid (LCFA). However, much remains to be understood about the molecular mechanism of the cardio-myopathy observed in CD36-KO mice. In this study, we identify different genes pathways involved in response to CD36 cardio-myopathy phenotype by identifying the differences among biological processes, molecular pathways and networks of interactions that emerge from knocking CD3 and using different bioinformatics tools such as STRING, GeneMANIA and Cytoscape. We were able list all the CD36-regulated genes, their related function and their specific networks. Data analysis showed that CD36-regulated genes differentially expressed are involved in biological processes such as FA metabolism, angiogenesis/apoptosis and cell structure. These results provide the first look at mechanisms involved in CD36 deficiency and development of cardio-myopathy and the opportunity to identify new therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Sabaouni et al. (2016) studied Hypertrophic cardiomyopathy (CD36 deficiency). CD36 Knock-Out vs. Wild type (WT-CD36) was evaluated on Differentially expressed genes. CD36 deficiency in mice led to the differential expression of 30 genes involved in fatty acid metabolism, angiogenesis/apoptosis, and cell structure pathways.
Synapse has enriched 10 related papers. Consider them for comparative context: